Get the Stockscreener App
24.78
1.62%
-0.4072
After Hours:
24.70
-0.08
-0.32%
Amplify Weight Loss Drug Treatment Etf stock is traded at $24.78, with a volume of 5,499.
It is down -1.62% in the last 24 hours and down -5.97% over the past month.
See More
Previous Close:
$25.19
Open:
$24.9
24h Volume:
5,499
Relative Volume:
1.82
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.69%
1M Performance:
-5.97%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$24.69
$24.90
1-Week Range:
$24.69
$25.33
52-Week Range:
$24.69
$28.19
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Company Profile
Name
Amplify Weight Loss Drug Treatment Etf
Sector
Industry
Phone
-
Address
-
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Latest News
Amplify ETFs Hits $10 Billion in Assets Amid New ETF LaunchesVettaFiCommentaries - Advisor Perspectives
(THNR) Investment Analysis and Advice - Stock Traders Daily
JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail
When the Price of (THNR) Talks, People Listen - Stock Traders Daily
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR - Yahoo Finance
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win - Yahoo Finance
(THNR) Trading Signals - Stock Traders Daily
7 Best Marijuana ETFs to Consider in 2024 - The Motley Fool
(THNR) Technical Pivots with Risk Controls - Stock Traders Daily
Tap the Weight-Loss Drug Market With These ETFs - Yahoo Finance
Long Term Trading Analysis for (THNR) - Stock Traders Daily
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst - MSN
Nervous about Nvidia? Here are some other stocks to consider - Yahoo Finance UK
3 ETFs to stabilize a portfolio amid volatility: Amplify CEO - Yahoo Finance
Harbour Investments Inc. Sells 275 Shares of First Trust Nasdaq Artificial Intelligence and Robotics ETF (NASDAQ:ROBT) - Defense World
Humana Inc. (NYSE:HUM) Shares Acquired by Harbour Investments Inc. - Defense World
Harbour Investments Inc. Has $166,000 Holdings in Innovator U.S. Equity Buffer ETF – June (BATS:BJUN) - Defense World
Harbour Investments Inc. Acquires New Position in Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR) - Defense World
F M Investments LLC Invests $1.57 Million in General Motors (NYSE:GM) - Defense World
(THNR) Investment Report - Stock Traders Daily
8 weight-loss stocks for a fatter wallet as drugs like Ozempic supercharge the healthcare industry - Business Insider
Disruptive Theme of the Week: Playing Defense - ETFdb.com
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
5 ETFs to Make the Most of Eli Lilly's Strength - MSN
'Ozempic breasts' to 'Ozempic face': What you need to know about weight loss drug side effects - Yahoo News Canada
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - Yahoo News UK
Dr. Sanjay Gupta On Call: What are your questions about weight loss drugs? - Yahoo Lifestyle UK
This Popular Weight Loss Drug May Help People With Sleep Apnea, Study Finds - Yahoo News Canada
Weight loss drug Zepbound outperforms Ozempic in new published study - Yahoo News Canada
Weight loss drug may cut heart failure risk, company says - Yahoo News Australia
Novo Nordisk's Wegovy gets UK approval for use to lower heart risks - Yahoo News UK
Oats could mimic effects of weight loss drugs, new study finds - Yahoo Lifestyle UK
Stephen Fry 'threw up five times a day' while using Ozempic - Yahoo News UK
Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity - Yahoo News Canada
NC Medicaid to cover weight-loss drugs like Wegovy, after access cut for state workers - Yahoo News Canada
ETFs in Focus as Competition Heats Up in Weight Loss Drug Segment - Yahoo Finance
Oprah Sets ABC Special on Ozempic and More Weight Loss Drugs After Exiting WeightWatchers Board - Yahoo News Canada
Returns Spiking for This Rate-Sensitive ETFVettaFiCommentaries - Advisor Perspectives
Would you consider taking weight loss drugs like Ozempic? Poll of the week - Yahoo Lifestyle UK
Hunter McGrady says she was 'utterly miserable' as a 'size 2/4': 'Weight loss doesn't always equate to confidence' - Yahoo Canada Shine On
HRTS: Exposure To GLP-1 Drug Developers Means Plenty Of Upside - Seeking Alpha
Make Money and Live Better With These Health Investing Tips - Bloomberg
Where to Invest in Health Trends - Bloomberg
Ozempic may reduce dementia: Research - Yahoo New Zealand News
THNR News Today | Why did Amplify Weight Loss Drug & Treatment ETF go up today? - MarketBeat
ETF Innovators: 11 people disrupting the industry, creating unique products, and delivering mammoth returns - Business Insider
A weight loss miracle! New shot does better than Ozempic and Wegovy during trials - Yahoo Singapore News
Amplify Weight Loss Drug Treatment Etf Stock (THNR) Financials Data
There is no financial data for Amplify Weight Loss Drug Treatment Etf (THNR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.69%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):